Oxford Asset Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Oxford Asset Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-99,398	Closed	-$1.65M	–	1638
2019 Q4	$1.65M	Sell	99,398 -32,360	-25%	-$525K	0.05%	540
2019 Q3	$2.19M	Sell	131,758 -30,919	-19%	-$428K	0.05%	487
2019 Q2	$2.24M	Buy	162,677 +53,531	+49%	+$819K	0.05%	597
2019 Q1	$1.88M	Sell	109,146 -7,824	-7%	-$124K	0.04%	616
2018 Q4	$1.5M	Buy	116,970 +34,336	+42%	+$521K	0.04%	637
2018 Q3	$1.34M	Sell	82,634 -33,637	-29%	-$481K	0.03%	873
2018 Q2	$1.51M	Buy	+116,271	New	+$1.57M	0.03%	828

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Oxford Asset Management's OXFD Position: Q1 2020 in Review

Oxford Asset Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2020, closing a stake of 99,398 shares — an estimated $1.65M sold.

Oxford Asset Management first reported a position in OXFD in Q2 2018 and held it in 7 quarters. The position peaked at $2.24M in Q2 2019. 65 funds tracked by Wall St. Rank hold OXFD as of Q1 2020.

Oxford Asset Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 99,398 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2020, an estimated $1.65M.
Oxford Asset Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2018 and held it in 7 quarters.
Oxford Asset Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $2.24M in Q2 2019.
65 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.